HopeStage
Back to all studies
CompletedNCT01172873

D-Cycloserine Added to Exposure Therapy for OCD

About this titleRead the official source — NCT01172873
Medication studyAges 12–17United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 12 years to 17 years.

Listed locations
New YorkSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2008
Recruitment status
Completed
Enrollment listed in the registry
16
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Behavioral
Intervention type
Behavioural, Drug
Locations
United States
Age range
From 12 Years to 17 Years
Official registry ID
NCT01172873
Official title
Show the full official title

Open-Label Exploratory Investigation of D-Cycloserine Augmentation to Cognitive Behavioral Therapy With Exposure and Response Prevention for Adults and Adolescents Diagnosed With Obsessive Compulsive Disorder - A Feasibility Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Did this study involve medication?

Yes. The study involved medication, including D-cycloserine.

Who was this study for?

Listed age limits: 12 years to 17 years.

Want to explore more studies?

Explore studies